Noradrenergic Activity, Cognition and Major Depressive Disorder
NCT02470026
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
131
Enrollment
OTHER
Sponsor class
Conditions
Major Depressive Disorder
Early Life Trauma
Interventions
DRUG:
yohimbine
DRUG:
placebo
Sponsor
Charite University, Berlin, Germany